BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 25, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Micromet, Bayer preclinical data

In mouse xenograft models of prostate cancer, daily 0.05, 0.5 and 5 mg/kg IV MT112/BAY 2010112 significantly reduced mean tumor volume vs. vehicle-treated controls...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >